BioCentury
ARTICLE | Company News

OncoMethylome, GlaxoSmithKline deal

October 4, 2010 7:00 AM UTC

OncoMethylome granted GlaxoSmithKline's GlaxoSmithKline Biologicals S.A. subsidiary rights to an undisclosed methylation-specific biomarker. GSK will use the biomarker to develop a diagnostic for its ...